Stockscreener 앱 받기
4.90
1.80%
-0.09
전일 마감가:
$4.99
열려 있는:
$4.96
하루 거래량:
38,881
Relative Volume:
0.34
시가총액:
$277.00M
수익:
$34.16M
순이익/손실:
$-98.43M
주가수익비율:
-2.094
EPS:
-2.34
순현금흐름:
$-119.33M
1주 성능:
-9.76%
1개월 성능:
-1.61%
6개월 성능:
+10.61%
1년 성능:
-47.08%
1일 변동 폭
$4.87
$5.02
1주일 범위
$4.87
$5.5825
52주 변동 폭
$2.9448
$10.25
Foghorn Therapeutics Inc Stock (FHTX) Company Profile
명칭
Foghorn Therapeutics Inc
전화
617-586-3100
주소
500 TECHNOLOGY SQUARE, CAMBRIDGE
FHTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FHTX
Foghorn Therapeutics Inc
|
4.90 | 282.08M | 34.16M | -98.43M | -119.33M | -2.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-23 | 개시 | Citizens JMP | Mkt Outperform |
| 2025-01-30 | 개시 | B. Riley Securities | Buy |
| 2024-09-03 | 개시 | Jefferies | Buy |
| 2024-08-19 | 개시 | Evercore ISI | Outperform |
| 2023-03-28 | 개시 | BofA Securities | Buy |
| 2023-01-05 | 개시 | BMO Capital Markets | Outperform |
| 2021-11-22 | 개시 | H.C. Wainwright | Buy |
| 2020-11-17 | 개시 | Cowen | Outperform |
| 2020-11-17 | 개시 | Goldman | Buy |
| 2020-11-17 | 개시 | Morgan Stanley | Overweight |
| 2020-11-17 | 개시 | Wedbush | Outperform |
모두보기
Foghorn Therapeutics Inc 주식(FHTX)의 최신 뉴스
Is Foghorn Therapeutics Inc. a candidate for recovery playGap Up & Community Shared Stock Ideas - newser.com
Advanced analytics toolkit walkthrough for Foghorn Therapeutics Inc.2025 Sector Review & Proven Capital Preservation Methods - newser.com
Smart tools for monitoring Foghorn Therapeutics Inc.’s price action2025 Investor Takeaways & Capital Efficiency Focused Strategies - newser.com
Risk Check: Does Foghorn Therapeutics Inc. stock benefit from AI growthQuarterly Portfolio Summary & Stepwise Entry/Exit Trade Alerts - خودرو بانک
Will Foghorn Therapeutics Inc. stock recover after recent drop2025 Market Overview & Trade Opportunity Analysis - newser.com
Chart based exit strategy for Foghorn Therapeutics Inc.2025 Market Trends & Community Consensus Stock Picks - newser.com
Aug Levels: Is Foghorn Therapeutics Inc a good ESG investmentDollar Strength & Real-Time Sentiment Analysis - خودرو بانک
US Market Wrap: Is Foghorn Therapeutics Inc stock a good dividend stock2025 Performance Recap & Low Drawdown Momentum Ideas - خودرو بانک
Trend Recap: Is Foghorn Therapeutics Inc part of any major indexJuly 2025 Analyst Calls & Stepwise Entry and Exit Trade Signals - خودرو بانک
Buybacks Report: Can Foghorn Therapeutics Inc. expand into new markets2025 Key Lessons & Fast Entry Momentum Trade Alerts - خودرو بانک
Energy Moves: Does Foghorn Therapeutics Inc. have pricing power2025 Retail Activity & Growth Oriented Trading Recommendations - خودرو بانک
Is Foghorn Therapeutics Inc. still worth holding after the dipJuly 2025 Movers & Safe Capital Investment Plans - newser.com
Order flow analysis tools used on Foghorn Therapeutics Inc.Exit Point & Verified High Yield Trade Plans - newser.com
What to expect from Foghorn Therapeutics Inc. in the next 30 daysJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
106,980 Shares in Foghorn Therapeutics Inc. $FHTX Purchased by SCS Capital Management LLC - MarketBeat
Reversal indicators forming on Foghorn Therapeutics Inc. stockMarket Growth Summary & Daily Chart Pattern Signals - newser.com
Published on: 2025-09-14 09:22:17 - newser.com
Published on: 2025-09-14 08:57:14 - newser.com
Is Foghorn Therapeutics Inc. stock poised for growthQuarterly Portfolio Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Short interest data insights for Foghorn Therapeutics Inc.July 2025 Drop Watch & Long Hold Capital Preservation Tips - newser.com
Can machine learning forecast Foghorn Therapeutics Inc. recovery2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
Is this a good reentry point in Foghorn Therapeutics Inc.Entry Point & Precise Buy Zone Identification - Newser
Analyzing net buyer seller activity in Foghorn Therapeutics Inc.Rate Hike & Daily Growth Stock Investment Tips - Newser
Earnings visualization tools for Foghorn Therapeutics Inc.2025 Price Targets & Free Long-Term Investment Growth Plans - Newser
Can Foghorn Therapeutics Inc. stock double in the next yearQuarterly Growth Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
Technical signs of recovery in Foghorn Therapeutics Inc.Weekly Stock Analysis & Low Risk Growth Stock Ideas - Newser
Foghorn Therapeutics Inc. stock momentum explainedPortfolio Value Report & Growth Focused Entry Reports - Newser
Is Foghorn Therapeutics Inc. forming a bottoming base2025 Geopolitical Influence & Reliable Volume Spike Alerts - Newser
Backtesting results for Foghorn Therapeutics Inc. trading strategiesVolume Spike & Real-Time Price Movement Reports - Newser
Developing predictive dashboards with Foghorn Therapeutics Inc. dataJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - Newser
Is Foghorn Therapeutics Inc. stock reversal real or fakeJuly 2025 Intraday Action & Free Weekly Watchlist of Top Performers - Newser
What MACD signals say about Foghorn Therapeutics Inc.2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - Newser
Can a trend reversal in Foghorn Therapeutics Inc. lead to recovery2025 Top Gainers & Reliable Price Breakout Signals - Newser
Key metrics from Foghorn Therapeutics Inc.’s quarterly data2025 Major Catalysts & Technical Entry and Exit Tips - Newser
What recovery options are there for Foghorn Therapeutics Inc.2025 Technical Patterns & Free Community Consensus Stock Picks - Newser
Nuveen LLC Makes New $221,000 Investment in Foghorn Therapeutics Inc. $FHTX - MarketBeat
Foghorn Therapeutics Inc (FHTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.77%
1.53%
자본화:
|
볼륨(24시간):